Clinical Trials Logo
  1. Home
  2. Other
  3. NCT04734756

Safety and Effectiveness Study of Dragonfly System for Degenerative Mitral Regurgitation

Degenerative Mitral Valve Disease Clinical Trial

Official title:
A Prospective, Multicenter, Objective Performance Criteria Study to Evaluate the Safety and Effectiveness of Dragonfly Transcatheter Mitral Valve Repair System for the Treatment of Degenerative Mitral Regurgitation (DMR) Subjects.

Clinical Trial Summary

To confirm the effectiveness and safety of the Dragonfly transcatheter mitral valve repair system for the treatment of symptomatic moderate-to-severe(3+) or severe(4+) degenerative mitral regurgitation (DMR) in high surgical risk subjects.

Clinical Trial Description

This study is a prospective, multicenter, objective performance criteria design. Patients are clinically symptomatic patients with chronic moderate to severe (3+) or severe (4+) organic mitral regurgitation (DMR) who were assessed as high risk for surgical procedures by the cardiac team at the local clinical trial site. After signing an informed consent form, subjects are enrolled and treated with the DragonFly Transcatheter Mitral Valve Repair System. All subjects receive clinical follow-up immediately after the procedure, before discharge, and 30 days, 6 months, and 12 months after the procedure. Treatment success at 12 months is used as the primary endpoint, with the definition as freedom from death, valve dysfunction surgery, and moderately severe or severe mitral regurgitation (MR >2+) at 12 months. The secondary endpoints include acute procedural success, acute device success, and surgery for valve dysfunction, NYHA class I or II at 30 days, 6 months, and 12 months, and the improvement in the quality of life change from baseline as assessed by the Kansas City Cardiomyopathy Questionnaire (KCCQ) score at 12 months after the procedure. The safety endpoints include major adverse events (MAEs), all-cause mortality, and cardiac mortality at 30 days, 6 months, and 12 months after the procedure. To evaluate the safety and effectiveness of the Valgen Medtech DragonFly Transcatheter Mitral Valve Repair System in the treatment of patients with clinically significant chronic moderate (3+) or severe (4+) degenerative mitral regurgitation (DMR) who have been evaluated by the local heart team as being at high surgical risk, and to evaluate the product performance. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04734756
Study type Interventional
Source Hangzhou Valgen Medtech Co., Ltd
Contact
Status Enrolling by invitation
Phase N/A
Start date May 4, 2021
Completion date May 31, 2027
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03290872 - Mitral Annuloplasty Rings RCT N/A
Completed NCT05774769 - Commissural Closure to Treat Severe Mitral Regurgitation: Standing the Test of Time.
Completed NCT05836532 - Long Term Results of Surgical and Percutaneous Double Orefices Mitral Repair in Patient With p2 Prolapse Causing Degenerative Mitral Regurgitation
Completed NCT05839782 - Long Term Results in Redo Mitral Valve Surgery After Mitral Valve Repair
Recruiting NCT03706833 - Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial N/A
Recruiting NCT05655897 - Safety and Efficacy of the GeminiOne Transcatheter Valve Edge-to-Edge Repair System in Patients With Moderate-severe or Severe Degenerative Mitral Regurgitation N/A
Enrolling by invitation NCT04067635 - Primary Mitral Regurgitation Repair
Active, not recruiting NCT06021509 - Clinical Study of NovoClasp for Treating Moderate to Severe and Severe Degenerative Mitral Regurgitation N/A
Not yet recruiting NCT04679662 - EXPLORE DMR: Early Feasibility Study of the PLAR Implant and Delivery System to Treat Degenerative Mitral Regurgitation N/A
Active, not recruiting NCT04281940 - Chordal Repair for Transcatheter Mitral Valve Repair (TMVr) N/A
Not yet recruiting NCT05417945 - A Prospective, Multicenter Study to Evaluate the JensClip Transcatheter Valve Repair System N/A
Recruiting NCT03433274 - Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation N/A
Active, not recruiting NCT03674593 - Clinical and Fundamental Aspects of Prosthetics and Translocation of Mitral Valve Chordae N/A
Recruiting NCT05595226 - Effect of RT3D-TEE-guided Mitral Valve Repair on Outcomes in Patients With Degenerative Mitral Valve Disease N/A
Terminated NCT04666480 - Early Feasibility Study of the PLAR Implant and Delivery System to Treat Degenerative Mitral Regurgitation N/A